VAST - Ventricular Arrhythmia Suppression Trial
NCT00158912 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 550
Last updated 2006-11-22
Summary
The purpose of VAST is to determine whether the Rate Smoothing feature in Guidant's PRIZM/VITALITY-family ICDs has an effect on the incidence of ventricular tachyarrhythmias.
Conditions
- Tachycardia
Interventions
- DEVICE
-
Implantable Cardioverter Defibrillator
Sponsors & Collaborators
-
Boston Scientific Corporation
lead INDUSTRY
Principal Investigators
-
Paul Friedman, MD · Mayo Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-08-31
- Completion
- 2005-05-31
More Related Trials
-
Ventricular Rate Regularization for Improved Quality of Life in Patients With CHF and AF
NCT00583921 ·Status: WITHDRAWN
-
Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic Preference (VIP)
NCT00311168 ·Status: COMPLETED ·Phase: NA
-
Testing Objective Methods for Template Matching Ventricular Tachycardia and Pacemapping
NCT01170416 ·Status: COMPLETED
-
Improve Sudden Cardiac Arrest Study
NCT02099721 ·Status: COMPLETED ·Phase: NA
-
Comparison of Right Ventricular Septal and Right Ventricular Apical Pacing in Patients Receiving a CRT-D Device
NCT00833352 ·Status: COMPLETED ·Phase: NA
-
INTRINSIC RV - Inhibition of Unnecessary RV Pacing With AV Search Hysteresis in ICDs
NCT00148967 ·Status: COMPLETED ·Phase: PHASE4
-
LVSP Based CRT vs. RVAP Based CRT
NCT05985408 ·Status: UNKNOWN ·Phase: NA
-
ECG Signal Collection From Long QT Syndrome, Wide QRS Complexes, Heart Failure, and Cardiac Resynchronization Patients
NCT00399412 ·Status: COMPLETED
-
Pilot Study of Hypertrophic Cardiomyopathy & Implantable Cardioverter Defibrillator Assessment: (Subcutaneous vs Transvenous)
NCT05938283 ·Status: COMPLETED ·Phase: NA
-
Acute Feasibility Investigation of a New S-ICD Electrode
NCT03802110 ·Status: COMPLETED ·Phase: NA
-
MASTER II - Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients
NCT00305214 ·Status: COMPLETED ·Phase: NA
-
EVITA: Evaluation of VIP Feature in Pacemaker Patients
NCT00366158 ·Status: COMPLETED ·Phase: NA
-
The Effects of Selective Site Right Ventricular Pacing
NCT02153242 ·Status: COMPLETED
-
Supraventricular Tachycardia Collection Study
NCT02158728 ·Status: COMPLETED
-
Interventricular Delay of Lumax HF-T for Heart Failure
NCT00508391 ·Status: COMPLETED ·Phase: PHASE2
-
A PRospective, rAndomizEd Comparison of subcuTaneOous and tRansvenous ImplANtable Cardioverter Defibrillator Therapy
NCT01296022 ·Status: UNKNOWN ·Phase: NA
-
Non-Invasive 3D Mapping for Identifying Origin and Preferential Propagation of Ventricular Arrhythmias
NCT03831516 ·Status: COMPLETED
-
Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators
NCT00035490 ·Status: COMPLETED ·Phase: PHASE3
-
Dual-Site LV Pacing in CRT Non Responders: Multicenter Randomized Trial
NCT01059175 ·Status: COMPLETED ·Phase: NA
-
MAgnetic Resonance Imaging-guided implanTation of Cardioverter DEFibrillators
NCT06269692 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
LifeVest Post-CABG Registry
NCT01448005 ·Status: TERMINATED
-
Antiarrhythmics Versus Implantable Defibrillators (AVID)
NCT00000531 ·Status: COMPLETED ·Phase: PHASE3
-
Sensing Ventricular Arrhythmias by His Bundle Leads
NCT03530423 ·Status: WITHDRAWN
-
Evaluation of Left Ventricular AutoThreshold
NCT00812201 ·Status: COMPLETED
-
ELEVATE (Evaluation of Left Ventricular Autothreshold) 3.0
NCT01539629 ·Status: COMPLETED